Viral Oncogenes and Their Role in Cancer Pathogenesis
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Infectious Agents and Cancer".
Deadline for manuscript submissions: 21 May 2025 | Viewed by 74
Special Issue Editors
Interests: HBV; HDV; HSV; hRSV; coronavirus; EBV; ZIKV
Special Issue Information
Dear Colleagues,
We are pleased to announce the call for submissions for a Special Issue of cancers focusing on the topic of "Viral Oncogenes and Their Role in Cancer Pathogenesis".
Viruses have long been recognized as significant contributors to cancer development. They achieve this by either expressing viral oncogenes or altering the cellular regulation of endogenous oncogenes. These oncogenes can modify host cell signaling pathways, leading to uncontrolled cell proliferation, evasion of apoptosis, and genomic instability. The study of viral oncogenes and the cellular regulation modifications that they induce has provided valuable insights into the molecular mechanisms underlying tumorigenesis, offering potential targets for therapeutic interventions. This Special Issue will explore the diverse array of viral strategies aimed at inducing oncogenesis identified across different viral families, their interactions with the host cellular machinery, and their impact on cancer pathogenesis. By elucidating the intricate relationship between viruses and cancer, this Special Issue will advance our understanding of oncogenic processes and pave the way for innovative antiviral and anticancer strategies.
All submitted articles will undergo a rigorous peer review process to ensure that they are of the highest scientific quality and are relevant to the field. We encourage contributions from researchers, clinicians, and experts in this field.
Should you have any questions, require further information, or need any assistance, please do not hesitate to reach out to us. We are here to support and facilitate your participation in this Special Issue
Thank you for your attention regarding this matter; we look forward to receiving your valuable submissions.
Dr. Ronen Borenstein
Dr. Yosef Sabo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- viral oncogenes
- cancer pathogenesis
- cellular regulation
- tumorigenesis mechanisms
- antiviral and anticancer strategies
